BJDX (Bluejay Diagnostics, Inc. Common Stock) Stock Analysis - Community

Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of May 21, 2026, BJDX trades at $1.79 with a market cap of $1.78M and a P/E ratio of -0.11. BJDX moved +0.00% today. Year to date, BJDX is -32.95%; over the trailing twelve months it is -76.73%. Its 52-week range spans $1.62 to $49.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade BJDX?

Rallies community data for BJDX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

BJDX Key Metrics

Key financial metrics for BJDX
MetricValue
Price$1.79
Market Cap$1.78M
P/E Ratio-0.11
EPS$-15.25
Dividend Yield0.00%
52-Week High$49.80
52-Week Low$1.62
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$-6.85M
Gross Margin0.00%

Latest BJDX News

Recent BJDX Insider Trades

  • Wurth Douglas Clark bought 12.50K (~$25.00K) on Mar 14, 2026.
  • Dey Indranil bought 12.50K (~$25.00K) on Mar 14, 2026.
  • CHASE DONALD R bought 12.50K (~$25.00K) on Mar 14, 2026.

BJDX Analyst Consensus

BJDX analyst coverage data. Average price target: $0.00.

Common questions about BJDX

How does the Rallies community trade BJDX?
Rallies community data for BJDX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for BJDX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for BJDX when enough community data is available.
Is BJDX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.
BJDX

BJDX